The role of АВС transporters in drug resistance to bortezomib in multiple myeloma-Reference-Cited by-同舟云学术

The role of АВС transporters in drug resistance to bortezomib in multiple myeloma

Published:2019-04-28 Issue:1 Volume:6 Page:49-56
ISSN:2413-3787
Container-title:Advances in molecular oncology
language:
Short-container-title:Usp. mol. onkol

Author:

Laletina L. A.¹^ORCID,Moiseeva N. I.¹^ORCID,Klimova D. A.¹^ORCID,Stavrovskaya A. A.¹

Affiliation:

1. Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Publisher

Publishing House ABV Press

Subject

Cancer Research,Biochemistry, medical,Genetics(clinical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference25 articles.

1. Bessmaltsev S.S. Multiple myeloma(pathogenesis, clinic, diagnosis, differential diagnosis). Klinicheskaya onkogematologiya = Clinical Oncohematology 2013;6(3):237—57.(In Russ.).

2. Moreau P., San Miguel J., Sonneveld P. et al. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28(suppl 4):iv52-61. DOI: 10.1093/annonc/mdx096. PMID: 28453614.

3. Stavrovskaya A.A., Gens G.P. Some new aspects of the study of multidrug resistance of tumor cells. Espekhi molekulyarnoy onkologii = Advances in Molecular Oncology 2014;(1):5—11. (In Russ.).

4. Robey R., Pluchino K., Hall M. et al. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer 2018;18(7):452—64. DOI: 10.1038/s41568-018-0005-8. PMID: 29643473.

5. Eliseeva I.A., Kim E.R., Guryanov S.G. et al. Boxing BINDING PROTEin 1 (YB-1) and its functions. Uspekhi biologicheskoy khimii = Advances in Biological Chemistry 2011;51:65-132. (In Russ.).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of preexisting drug resistance due to overexpression of P-glycoprotein for the formation of resistance to bortezomib;Advances in Molecular Oncology;2020-03-29